| Mr William Frederick Ehni, MD | |
|
21701 76th Ave W, Edmonds, WA 98026-7536 | |
| (425) 744-1740 | |
| Not Available |
| Full Name | Mr William Frederick Ehni |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 42 Years |
| Location | 21701 76th Ave W, Edmonds, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679502264 | NPI | - | NPPES |
| 1028216 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | AE2700385 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Washington Medical Ctr | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report from researchers at Massachusetts General Hospital (MGH) has been published online in Nature Communications.
Researchers at the University of Cincinnati have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women between 25 and 54 who come to the emergency room for the first time with a collapsed lung.
Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
Gilead Sciences, Inc. provided an update today on the development of the fixed-dose combination of Truvada (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride, 25 mg).
› Verified 7 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report from researchers at Massachusetts General Hospital (MGH) has been published online in Nature Communications.
Researchers at the University of Cincinnati have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women between 25 and 54 who come to the emergency room for the first time with a collapsed lung.
Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
Gilead Sciences, Inc. provided an update today on the development of the fixed-dose combination of Truvada (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride, 25 mg).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr William Frederick Ehni, MD 1012 Nw 199th St, Shoreline, WA 98177-2642 Ph: (206) 546-4939 | Mr William Frederick Ehni, MD 21701 76th Ave W, Edmonds, WA 98026-7536 Ph: (425) 744-1740 |
News Archive
Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report from researchers at Massachusetts General Hospital (MGH) has been published online in Nature Communications.
Researchers at the University of Cincinnati have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women between 25 and 54 who come to the emergency room for the first time with a collapsed lung.
Pain is more than a symptom of osteoarthritis, it is an inherent and damaging part of the disease itself, according to a study published today in journal Arthritis and Rheumatism.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
Gilead Sciences, Inc. provided an update today on the development of the fixed-dose combination of Truvada (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride, 25 mg).
› Verified 7 days ago
Alexander C Chung, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 Fax: 425-640-4010 | |
Shen-li Tan, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 7320 216th St Sw, Ste 210, Edmonds, WA 98026 Phone: 425-744-1777 Fax: 425-744-1790 | |
Anita Chopra, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7320 216th St Sw Ste 200, Edmonds, WA 98026 Phone: 425-640-4900 Fax: 425-640-4919 | |
Drake William Cramer, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 7320 216th St Sw Ste 200, Edmonds, WA 98026 Phone: 425-640-4900 Fax: 425-640-4919 | |
Douglas D Mcmillen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 23320 Hwy 99, Edmonds, WA 98026 Phone: 425-640-5500 Fax: 425-640-5520 | |
Dr. Elaine Yilin Shao, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 21600 Highway 99 Ste 230, Edmonds, WA 98026 Phone: 206-215-4250 Fax: 206-215-4252 | |
Andrew Knubel Perry, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 21710 76th Ave W, Suite 300, Edmonds, WA 98026 Phone: 425-640-5500 Fax: 425-640-5520 |